Additional Funding Raises: #Nuclidium €84 million Series B; #CarOnSale €70M Series C; #Actithera $75.5M Series A; #Nabla $70M Series C; #ActioBiosciences $66M Series B; #Abacum $60M Series B; #Huspy $59M Series B; #AllayTherapeutics $57.5M Series D; #LookUp €50M Series A